receptor encoding genes remains poorly understood. Recently, two genes, RAGl and RAG2, that are able to activate rearrangement of synthetic recombination substrates were cloned in mouse and a human gene homologous to RAGl was described. To define the differentiation stages corresponding to RAGl and RAG2 RNA expression, we have studied a large number of B-and T-lymphoid neoplasias. First, we show that a human gene homologous to the murine RAG2 is transcribed in humans. Moreover, using a polymerase chain reaction approach, we have shown that RAG are expressed not only in T-cell receptor (TCR)-negative T-cell acute lymphoblastic leukemias (T-ALLs), but also in some cases in which a significant percentage of cells ex-HE SPECIFICITY of antigen recognition by lymphoid T cells is mediated by surface-expressed antigen receptors whose diversity results mainly from clone-specific somatic rearrangements.',' These rearrangements occur during the early phases of lymphoid differentiation and involve multiple and dispersed V, J, and, in some cases, D segments that encode the variable portion of antigen receptors. Rearrangements are mediated by conserved recombination signal sequences (RSS)' consisting of a palindromic heptamer and an A-T-rich nonamer separated by a spacer of either 12 or 23 bp. RSS flank each rearranging segment. Use of engineered recombination substrates has shown that RSS alone are necessary and sufficient for targeting recombination irrespective of the coding sequences associated with RSS. The details of V-(D)-J recombination remain poorly understood but may include specific steps (binding to RSS, cleavage near RSS) and non-specific steps (deletions/additions of a random number of nucleotides, repair and ligati~n).~ Products of genes allowing binding to RSS5,6 and stabilization of an intermediate complex that holds the RSS in proximity are probably involved, as are certain enzymes (n~clease,"~ terminal deoxynucleotidyl transferase," and ligase). Most mechanisms are probably common to B and T cells because engineered T-cell receptor (TCR) recombination substrates rearrange when transfected in Abelson-transformed murine pre-B cells." Additional and not fully characterized mechanisms ensure that full rearrangements of Ig and TCR genes only occur in B and T cells, respectively.
T cells is mediated by surface-expressed antigen receptors whose diversity results mainly from clone-specific somatic rearrangements.',' These rearrangements occur during the early phases of lymphoid differentiation and involve multiple and dispersed V, J, and, in some cases, D segments that encode the variable portion of antigen receptors. Rearrangements are mediated by conserved recombination signal sequences (RSS)' consisting of a palindromic heptamer and an A-T-rich nonamer separated by a spacer of either 12 or 23 bp. RSS flank each rearranging segment. Use of engineered recombination substrates has shown that RSS alone are necessary and sufficient for targeting recombination irrespective of the coding sequences associated with RSS. The details of V-(D)-J recombination remain poorly understood but may include specific steps (binding to RSS, cleavage near RSS) and non-specific steps (deletions/additions of a random number of nucleotides, repair and ligati~n).~ Products of genes allowing binding to RSS5,6 and stabilization of an intermediate complex that holds the RSS in proximity are probably involved, as are certain enzymes (n~clease,"~ terminal deoxynucleotidyl transferase," and ligase). Most mechanisms are probably common to B and T cells because engineered T-cell receptor (TCR) recombination substrates rearrange when transfected in Abelson-transformed murine pre-B cells." Additional and not fully characterized mechanisms ensure that full rearrangements of Ig and TCR genes only occur in B and T cells, respectively.
A fundamental breakthrough in the understanding of antigen receptor assembly was obtained by the recent cloning of two lymphoid-specific genes, RAGl and RAG2, that activate V-(D)-J recombination.''-14 Murine RAG2 is located 8 kb downstream to RAGl.I4 RAGl and RAG2 appear to be coordinately transcribed in most cells. However, recently, selective expression of RAGl and RAG2 has been described in murine central nervous system" and chicken B cells undergoing Ig gene conversion,'6 respectively. The nucleotide sequences of these two genes are not homologous. Most of the structural sequences and 3' untranslated regions from RAGl and RAG2 are encoded by a single exon, suggesting that these genes, conserved through evolution, have evolved from viral or fungal genes. It has been shown that RAG differ from the murine scid gene that leads, when mutated, to a specific defect in V-J joining. When cotransfected into murine fibroblasts, RAG synergistically activate the rearrangement of a synthetic recombination substrate but not of endogenous antigen receptor genes. Because RAG are expressed in murine lymphoid cells at stages when the recombinase activity is high, it has been speculated that these genes are of fundamental importance for the V-(D)-J recombinations occurring in v~v o .~~, '~ Very little is known as yet concerning RAG expression in human cells and human RAG2 has not been definitively identified.
We analyze here the distribution of RAG messenger RNA (mRNA) in human leukemic cells frozen at various stages of differentiation. Using a polymerase chain reaction (PCR)-based strategy, RAG expression was studied in 73 cases of selected B-and T-acute leukemias. Chronic B-cell proliferations and established cell lines were also studied. We show evidence that a human RAG2 homologous to the murine gene is expressed and, as observed in the mouse, that RAGl and RAG2 are in most cases transcribed concordantly. Moreover, we show that RAG mRNAs are expressed in almost all early human pre-B leukemic cells T43  EM  T59  PB  T69  EM  T38  PB  T41  PB  T41r  EM  T42  PB  T42r  PB  T44  EM  T52  PB  T55r  PB  T57  PB  T60  PB  T64  PB  T65  PB  T7 1  BM  T72  BM  T73  PB  T43r  EM  T50  BM  T54  BM  T67  BM  T38r  PB  T49  EM  T61r  PB   95  96  84  90  88  96  97  96  91  90  100  97  92  87  89  100  79  95  95  95  92  46  80 Tables 1 and 2 . Studies of Ig/TCR gene rearrangements were performed by Southern blotting using appropriate probes and restriction enzymes as Some of the cases studied here have been included in previous contributions from our group. The corresponding cases were identified with a unique number used in these previously published reports.2F2S The pre-B Reh, the Tap Jurkat, and the epithelial Hela cell lines were used. Mononuclear cells obtained from healthy donors and purified by Ficoll separation and thymocytes obtained from a 2-year-old child during thoracic surgely were used in some experiments.
Extraction of total mRNAwas performed by the guanidium-cesium chloride method as described. 26 The cell pellet was lysed by vortexing into 6 mol/L guanidium isothiocyanate, 5
RNA isolation.
For personal use only. on September 24, 2017. by guest www.bloodjournal.org From
BORIES ET AL
mmol/L sodium citrate, 0.1 mol/L 8-mercapthoethanol, and 0.5% sarkosyl. The lysate was then centrifuged over a gradient of 5.6 mol/L cesium chloride at 77,OOOg for 16 hours at 20°C. RNA was precipitated ifi 70% ethanol and resuspended in diethylpyrocarbonate-treated water.
All RAGl oligonucleotides were derived from the human RAGl sequence." (RAG1: RAGlA = CAGCGTTTTGCTGAGCTCCT, RAGlB = GGCTTTCCA-GAGAGTCCTCA, RAGlT = AAGTATAGGTATGAGGGAA.) RAGlB was used for synthesis of RAGl cDNA, RAGlA and RAGlB were used for PCR amplification; RAGlT was used for the detection of PCR products. PCR amplification using RAGlA and RAGlB lead to the production of a 364-bp fragment. When this fragment is used as a probe, a 7-kb message is detected in pre-B cell RNA by Northern blotting (data not shown), consistent with previous reports.13 mR2A and mR2B were derived from the murine RAG2 sequence.I4 (RAG2: mR2A = AGATGGAGACTCCTGACTGG, mR2B = CCGTTGAATAGAACGGAACCC.) hR2A, hR2B, and hR2C were synthesized after sequencing of part of the human RAG2 (Fig 1, see below) . (hR2A TTCTTGGCATACCAGCAG, TCAAAGGGAGTGG.) hR2C was used for synthesis of RAG2 cDNA; hR2A and hR2C were used for PCR. hR2B was used for the detection of PCR products.
Oligonucleotides were also derived from the actin gene sequence CACAGGAC; AC3: CCATCTCTTGCTCGAAGTC). AC1 and AC2 were used as amplimers. AC3 was used as probe. One microgram of total RNA was heated at 92°C for 1 minute in a 20-kL mixture containing Tris-HC1 pH8.2, 50 mmol/L; MgCl,, 6 mmol/L; dithiothreitol, 10 mmol/L; KCI, 40 mmol/L; dATP, dGTP, dCTP, dTTF', 0.2 mmol/L; and 100 ng of the 3' primer (RAGlB, RAG2B or AC2) and subsequently chilled in ice for 3 minutes. Ten units of avian myeloblastosis virus (AMV) reverse transcriptase (Boehringer Mannheim, Maylan, France) was added. cDNA synthesis was performed at 37°C for 1 hour.
PCR2' was performed on the total cDNA reaction in 100 kL of Tris-Hcl pH 8.3, 10 mmol/L; KCI, 50 mmol/L; MgCI,, 2 mmol/L; gelatin 0.01% (wtivol); dATP, dGTP, dCTP, dl'TP 0.2 mmol/L; 100 ng of the 5' primer (RAGlA or RAG2A) and 2.5 U of Taq DNA polymerase were used. The first cycle consisted of 3 minutes at 92°C for denaturation, 1 minute at 55°C for annealing, and 1 minute at 72°C for elongation, followed by 28 cycles consisting of 1 minute at 92°C for denaturation, 1 minute at 55°C for annealing, and 1 minute at 72°C for elongation. The elongation time was increased by 2 seconds with each cycle; the 28th cycle elongation time was prolongated to 5 minutes to allow extension of incomplete DNA fragments.
Ten microliters of the PCR reaction mixture was loaded onto a 3% agarose gel, run in Tris/Borate/ EDTA (TBE) buffer, and stained in ethidium bromide.
Dot-blot hybridization of 10% of the products of PCR were performed on Hybond N membrane (Amersham, Les Ulis, France) with 5' labeled oligonucleotide (RAGlT, RAG2T, or AC3) for 1 hour in 5X SSPE, 5X Denhart's, 0.5% sodium dodecyl sulfate (SDS) at 46°C. After hybridization, membranes were washed twice in 2X SSPE, 0.1% SDS at room temperature and once in 5X SSPE, 0.1% SDS at 50°C for 10 minutes. Dots were exposed for 4 hours at -80°C with intensification screens.
Direct sequencing was performed after heat denaturation by standard methods. 28 Northern blots were performed as previously describedz6 on mRNA purified on oligo-dT columns. RAG 1 probe was obtained by PCR from DNA using RAGIA-RAGlB primers. 
181 TTT G1u GAC TCT Cna GAA TTT TCT TTC ACT CC& GAA GCA U ACT TTT GAA GdC TCA w)C GAA TTT TGT TTC ACT GCT GA. 4 GCA ACC ACT Probes were labeled by incorporation of P32-nucleotides with the Klenow polymerase using random hexamers.
Preliminary experiments showed that a large quantity of Poly-A RNA was necessary for the detection of RAG expression by Northern analy~is".'~ (data not shown). This strategy appeared impractical for the analysis of a large number of cryopreserved samples. We therefore undertook to analyze RAG expression by PCR amplification of cDNA obtained by a reverse transcriptase (RT) reaction primed with specific oligonucleotides To distinguish between illegitimate trans~ription'~~ and lowlevel transcription, we initially studied serial dilutions of RNA from the RAG+ cell line Reh into RNA from the RAG-cell line Hela. In almost all experiments, a low-level RAG transcription was detected in lo-* dilutions and in some cases RAGl (but no RAGZ) expression was observed in lo-' dilutions (Fig 2) . The level of illegitimate transcription observed in Hela was undetectable or at least lower than that observed in lo-' dilutions (Fig 1 and data not shown). A level similar to that observed in dilutions (quoted Strategy of the study.
(RT-PCR).
For personal use only. on September 24, 2017. by guest www.bloodjournal.org From M l 2 3 4 5 6 Actin " 2 " ) was considered to be low but potentially significant in samples obtained from PB. A level similar to that observed in the undiluted Reh cell line was considered to be high-level expression (quoted I ' + " ) . Undiluted and IO-* diluted Reh RNAs (into water or into RNA from the RAG-cell line Hela) were included in each experiment. The level observed in Reh is similar to that found in most B-and T-lineage ALLs (see below). No attempt was made to quantify the reaction more precisely. Each experiment was performed at least twice with consistent results (in most cases three or four independent experiments were performed).
It has been shown previously that most of the coding part of RAG is contained in only one exon. Sequences recognized by the primers used in this study were therefore located on the same exon. Because it was not possible to distinguish between amplified products derived from RNA and those corresponding to contaminating DNA on the basis of size, control reactions omitting the RT enzyme were performed in each case. Only samples with no contamination (signal lower than lo-') were included in the study.
To verify the quantity of RNA, a PCR reaction was performed on aliquots using primers directed against sequences of the f3-actin gene.
The usual procedures were performed to minimize the risk of carry-over. Controls samples without RNA were included in each experiment.
RESULTS
Transcription of a human gene (hRAG2) homologous to the murine RAG2. The existence of a human gene homologous to the murine RAG2 was suggested by three results: firstly, human or murine RAGI cDNA only activates V-( D ) J rearrangements poorly when used alone; secondly, human genomic DNA transfected into mouse fibroblasts activate recombination as efficiently as does murine genomic DNA containing RAGl and RAG2; finally, a sequence homologous to mRAG2 has been detected in human DNA by Southern blotting with a murine RAG2 p r~b e . '~ Because it has been reported previously that RAGl and RAG2 are concordantly transcribed in murine lymphoid cells,'4 we expected to detect expression of the human mRAG2 homologue gene from a RAG1-expressing human cell line. We first verified that RAGl mRNA are detectable in a pre-B cell line, Reh, and then used RNA from these cells in an RT-PCR experiment using murine RAG2 primers. These primers (mR2A and mR2B) were selected to amplify a DNA segment that contains the acidic region previously described by Oettinger et all4 that was potentially important for the function of the gene (Fig 1) .
A unique fragment was observed by electrophoresis whose size was consistent with that expected from the murine sequence. To verify that the RNA detected was homologous to murine RAG2 products, we then sequenced a 282-bp DNA fragment located in the PCR fragment. The nucleotide sequence shows a marked homology (2431282) to the murine gene (Fig 1) . No frame shift was observed and no major alteration of the deduced amino acid sequence (homology 78/94 amino acids) was noted. Finally, we verified that the PCR product was recognized by an oligonucleotide complimentary to the human sequence (hRB). The oligonucleotides (hR2A, hR2B. hR2C) designed from the human sequence were used in all subsequent experiments on RAG2 expression.
These data were considered reasonable evidence for the existence of a human gene homologous to the murine RAG2.
No RAG expression was detected in PB mononuclear cells from healthy donors (data not shown), consistent with the situation in the We next investigated thymocytes obtained from a 2-year-old child. Abundant RAGl and RAG2 messages were documented (data not shown). To delineate the stages of differentiation corresponding to RAG expression, we studied selected cases of T-ALLs that can be considered to be neoplastic expansions of cells frozen at discrete stages of thymic differentiation. Twenty-
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nine samples encompassing the major stages of early T-cell differentiation were analyzed (Table 1) . Representative experiments are shown in Fig 3. Coordinate RAGl and RAG2 expressions were observed in all cases. No correlation was found between the level of RAG expression and the type of analysed sample (PB v BM).
Clear RAGl and RAG2 expression (quoted "+") was found in 21 of 29 cases, including two cases of immature phenotype, 12 cases with common cortical phenotype, and five samples with a significant ( > 30%) percentage of CD3' up (T38r, T49) or yS (T31, T31r, T66) neoplastic cells. Interestingly, the very high percentage of CD3-yS expressing cells (96%) and of blast cells (95%) in the PB sample T31 suggested that TCR expression may coexist with RAG expression. We next compared RAG2 expression in undiluted and diluted T31 RNAs with that observed in dilutions of Reh RNAs. Expression in lo-' dilutions of T3l RNAs was clearly detectable, while no signal was observed in lo-' dilutions of Reh RNAs (Fig 4) . This finding suggests that RAG expression is not due to rare CD3-ve neoplastic cells but occurred in at least a part of CD3-ys' cells in this particular case.
Among the cases with no or minimal expression, one was immature (T69), five were of the common cortical stage or expressed only low level of surface CD3 (T42r, T64, T73, T43r, TSO), one expressed C D 3 4 (T61r), and one expressed CD3-y8 (T37) ( Table 2) . Although no CD19' B-lineage cells could be detected in the T43r case (Table l) , it is difficult to be sure that the minimal RAG expression observed in the BM sample is due to malignant cells (95% of nucleated cells) or to normal BM pre-B cells. Clonal TCRy rearrangements were documented in all of the RAG-ve cases (T69, T73, T50, T37; data not shown). This finding is consistent with the hypothesis that recombinase A c t i n Exp. 2 activity was in fact present in the precursors of these cells and suggests that some regulatory process was involved in the lack of RAG expression.
It was possible to compare in five cases RAG expression at presentation and during first relapse of the disease. In three cases (T41, T31, T38), identical findings were obtained. In the two last cases (T42, T43), RAG expression was clearly less intense during the relapse than at presentation.
These data show that RAG expression is found in most T-ALLs and suggest that recombinase activity may coexist in some cases with CD3-TCR expression.
Expression of hRAGI and hRA G2 in B-cell proliferations. Expression of RAGl and, at a more limited extent, of RAG2 has been previously studied by Northern analysis in murine-established cell It was shown that these genes are expressed in pre-B but not in mature B cells, nor in the very immature LyD9 cells that are engaged in the B-cell lineage. RAGl expression has also been previously documented in the human pre-B Namalva cell line.
To extend these data, we analyzed the expression of hRAGl and hRAG2 in human B-cell proliferations.
Because it has previously been shown that RAG may be untranscribed in very immature pre-B cells and in mature B cells, we did not use random cases but selected 41 sIg-A L L encompassing the major stages of early B-cell differentiation described by Nadler et al?' Eleven Nadler stage I1 (CD19'CDlO-CD20-), 11 Nadler stage I11 (CD19'CDlO+CD20-), and 19 more mature Nadler stage IV (CD19'CDlO'CD20+) cases were selected.
A clear RAGl andlor RAG2 expression was detected in 38 cases (Table 2 and Fig 5) . Although no rigorous quantitation can be made using our experimental procedure, expression of RAG compared with that of the p-actin gene was higher in some cases than in others. No evident B ~r p . --"L, correlation with stage of differentiation, as defined by CD19, CDlO, CD20, CD34, or Cp expression, could be shown (data not shown). In the great majority of cases, RAGl and RAG2 were coordinately transcribed ( Table 2) . 
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In seven cases, however, partial dissociation was observed (B67, B68, B38, B72, B73, B74r, and B75).
In two cases (B45 and B77) no expression or minimal RAG expression was observed (Table 2) . We analyzed the IgH locus and documented rearrangements in both cases with the JH probe (data not shown). We next verified that bi-allelic deletion of RAGl and RAG2 has not occurred in the case with no detectable expression (B77) by performing PCR amplification on DNA extracted from these cells (data not shown). Interestingly, neither C p nor sIg could be detected in either case.
We then analyzed sIg' B-cell proliferations. Three slg' ALLs (Burkitt's type) were studied. No RAGl and RAG2 expression was found ( Table 2 ). Nine B nodular lymphomas (BNL) and two B-chronic lymphocytic leukemias (B-CLL) were also analyzed, but no expression was found (data not shown).
These data show that RAGl and RAG2 are concordantly expressed in almost all early B-ALL and not in more mature sIg' proliferations.
DISCUSSION
Somatic recombinations are of fundamental importance in the generation of the repertoire that allows lymphoid cells to specifically recognize antigens. RAG should be included among the major factors involved in the mechanism and/or the control of gene rearrangements. This was shown by transfection experiments showing that the products of both genes act coordinately to efficiently induce rearrangements of recombination ~ubstrates.'~ The importance of RAG is also suggested by a high conservation of nucleotide and amino acid sequences among species. This was shown in the case of RAGl by comparing murine and human sequence^'^ and is also true in the case of RAG2, as RAG products may be involved in vivo in the control of gene rearrangements, as suggested by previous studies of established mouse cell lines showing restriction of RAG expression in lymphoid cells at differentiation stages characterized by high recombinase a~tivity.'~,'~ Our data show that this is probably also true of human lymphoid cells. Using a PCR approach, RAG RNA were found in thymocytes and in the majority of T-ALLs, but not in peripheral mononuclear cells. RAG1 and RAG2 RNA were also detected in almost all sIg-B-lineage ALLs, including pre-B and prepre-B cells, but was undetectable in the sIg' B-cell proliferations tested, including Burkitt's ALLs, follicular center cell lymphomas, and chronic leukemias.
Assuming that RAG play a necessary role in the control of V-(D)-J recombinations, it is tempting to speculate that RAG transcription is controlled by antigen receptor expression. Indeed, RAG expression would be unnecessary to antigen receptor expressing cells in which the relevant genes (ie, IgH-d1gH-h or TCRa-PITCRy-6) had undergone productive rearrangements. Control of RAG expression may thus be one of the mechanisms involved in allelic exclusion. Some exceptions to the inverse correlation between antigen receptor expression and RAG transcription were found, however, in the present study and may indicate that the control of RAG transcription is complex. Firstly, we were unable to detect RAG expression in at least one sIg-case in which the IgH genes had rearranged. Similarly, three CD3-TCR-T A L L cases in which the TCRy genes were rearranged did not express RAG. This lack of expression may be due to an as yet poorly understood consequence of the leukemic process on cell differentiation that impairs the control of RAG transcription. Alternatively, this may indicate that antigen receptor expression is not per se directly involved in RAG transcriptional regulation. The same conclusion is also supported by the finding that RAG are expressed in at least one CD3-TCR-expressing ALL. These data should be interpreted in light of the suggestion that TCR gene allelic exclusion is not absolute at the DNA level. We have recently shown that two potentially functional TCRy rearrangements can coexist in cells from T-ALLs." More significantly, others have shown that two TCRa rearrangements can be present in a CD3' T-cell clone?2 Moreover, replacement of a functional TCRa rearrangement by another functional TCRa rearrangement was shown in a CD3aP-expressing murine T-cell line obtained by retroviral transformation of thymo~ytes.3~3~~ If similar data are found in normal cells, this would imply that the ability to rearrange TCR genes is conserved in at least some CD3' thymocytes and may be important for the selection of the T-cell repertoire.
RAG transcription in immature B-or T-leukemic cells is also potentially important in the understanding of oncogenesis in lymphoid cells. It is now well established that many nonrandom translocations involving Ig/TCR genes in lymphoid neoplasias involve breakpoints that occur near RSS and probably involve mechanisms similar to those leading to V-(D)-J rearrangement^.^' These data were recently extended to chromosomal abnormalities occurring outside antigen receptor genes. For example, it was shown that deletions of the SCL/tal/TCW gene occurring in up to 30% of T-ALL involve heptamers identical to those found in RSS. Studies of nucleotide sequences at the chromosomal junctions have shown nucleotide deletions and additions very similar to those observed at V-(D)-J junctions.36 Therefore, it is possible that RAG products are involved in the pathogenesis of these chromosomal abnormalities.
From a less speculative point of view, the fact that neoplastic cells are frozen at a differentiation stage in which RAG are active may be important for practical reasons. Our group and others have recently shown that oligonucleotides directed against clone-specific V-(D)-J junctional sequences can be used to specific?lly detect malignant lymphoid cells even when they represent less than 1 of los ce11s.25,37-39 The use of such a strategy is hampered by oligoclonality and successive rearrangements. Oligoclonality is observed in the IgH locus in about 15% to 30% of B-lineage A L L s 4 0 but is rarely found with TCR genes. Alteration of TCR rearrangement patterns occurs in about 15% of the cases if samples obtained at presentation and at relapse are analyzed (one example of such cases, T38, is included in this study and is described in more detail in Macintyre et al). 25 There is presently no mean to detect those cases prone to clonal variation. It may be that high-level RAG expression is predictive of such an event. Quantitative PCR4' will be used in further studies to test this hypothesis. 
